Abridge excels in AI-driven summarization for clinical notes with strong integration capabilities, whereas Regard focuses on diagnostics and proactive documentation. Abridge is noted for its robust customer feedback and broad integration with major EHR systems, having raised $907.5M in Series E funding. Unlike Abridge, Regard lacks substantial user feedback, but it provides a unique approach to proactive diagnostics with Series B funding of $81.4M.
Best for
Abridge is the better choice when healthcare providers need robust conversation summaries integrated with major EHR systems and quick documentation outcomes.
Best for
Regard is the better choice when a healthcare organization seeks proactive diagnostic support and is cost-sensitive, requiring a broader range of compatible health data systems.
Key Differences
Verdict
Abridge is a clear choice for healthcare providers deeply integrated with specific EHR systems and needing streamlined clinical note-taking capabilities. Regard would benefit organizations aiming for cost-effective, proactive diagnostic tools interacting with diverse health data systems. Both tools offer unique features that serve distinct clinical and operational needs.
Abridge
Download whitepaper
Users generally praise Abridge for its AI-driven capabilities, particularly in summarizing conversations effectively, which is seen as a major strength. However, complaints often center around occasional inaccuracies in transcription or summary details. The pricing is perceived as somewhat high by some users, but others feel it offers good value considering its utility in producing professional results quickly. Overall, Abridge has a positive reputation, especially admired by those who need efficient documentation tools.
Regard
Regard reviews all data in the medical record to recommend diagnoses and generate a complete note at the point of care - improving care, quality, and
The reviews and social mentions do not provide any specific feedback or insights about "Regard", making it challenging to discern user opinions on the software. Given the lack of detailed user input, it is difficult to outline the main strengths, key complaints, pricing sentiment, or overall reputation of the tool. More targeted user feedback would be needed for a comprehensive analysis.
Abridge
Stable week-over-weekRegard
Stable week-over-weekAbridge
Regard
Abridge
Regard
Abridge
Regard
Pricing found: $7
Abridge (8)
Regard (2)
Only in Abridge (1)
Only in Regard (2)
Only in Abridge (15)
Only in Regard (8)
Abridge
No complaints found
Regard
Abridge
No data
Regard
Abridge
Regard
Abridge
Regard
Abridge
Regard
Is Flock just a poor US-centric copy of, globally active Genetec?
I've read all of Genetec's [customer stories](https://www.genetec.com/customer-stories/search) (the PDFs), and although I recognize these, as being Genetec marketing material (at least in part), they do contain insightful information, regarding implementation of surveillance systems; that is, from t
Shared (1)
Only in Abridge (1)
Abridge is better suited for clinical note summarization as it excels in AI-driven conversation summaries.
Abridge uses a tiered pricing model without specified starting costs, while Regard's pricing starts at $7, indicating Regard may be more budget-friendly.
Abridge appears to have more positive user engagement and community feedback, whereas Regard lacks detailed user insights publicly.
While they focus on different healthcare aspects, using them together could theoretically provide comprehensive documentation and diagnostic insights.
Abridge provides strong integration capabilities with major EHRs, likely facilitating smoother implementation for users already within those systems.
